adobe stock.com - EtiAmmos FinancingMosanna Therapeutics bags $80m in Series A roundObstructive sleep apnea (OSA) specialist Mosanna Therapeutics AG has secured US$80m in a Series A financing to fund clinical testing through Phase II of its nasal OSA spray MOS118. more ➔
BIO-CATGene and cell therapiesSpanish BIO-CAT cluster starts new ATMP acceleratorThe Spanish BIO-CAT cluster has launched a new accelerator called ATMP Catalyst, which will support six preclinical gene and cell therapy projects per year in each of three annual calls to support translation … more ➔
Frederick BernasBioeconomyBig deal: Amphistar goes transatlanticBelgian micriobial fermentation specialist AmphiStar NV has partnered with US plant-based ingredient heavyweight Kensing to market its biosurfactants in the US, using locally-produced feedstocks. Amphistar’s … more ➔
EFPIARegulationPharma industry calls EU pharma package counterproductivePharmaceutical associations have responded with sharp criticism to the adoption of the revised general pharmaceutical legislation by the EU Council of Ministers in the form of a directive and a regulation. … more ➔
Bristol Myers SquibbPartnershipsSuper deal for BioNTech – BMS licenses potential blockbuster for €10bnIn the race to replace MSD’s mega blockbuster pembrolizumab with a more effective bispecific VEGF x PD-(L)1 antibody, German company BioNTech SE has struck a good deal. BioNTech is now developing its … more ➔
Invest in Scotland, FlexBioEngineering biologyScotland’s bioeconomy gets scale-up boostScotland’s biotechnology sector is celebrating a major milestone with the launch of the nation’s first open-access 300-litre fermenter – a state-of-the-art piece of equipment that will support … more ➔
MichaelVi - stock.adobe.comColorectal cancerScientists uncover target to stop colitis-induced colorectal cancerGerman researchers have identified a promising new target to stop the inflammatory response in ulcerative colitis—a breakthrough that could help prevent the progression to colorectal cancer. Phase … more ➔
ECEuropean Commission EU set to improve investment for biotech start-ups and scale-upsThe European Commission has promised to create a new public-private fund to bridge the ‘valley of death’ phase for technology companies facing expansion. In addition, the EU wants to reduce its lag … more ➔
Norwegian Mycelium ASFermentationNorwegian Mycelium AS bags €1.25m to scale mycoprotein productionFoodtech startup Norwegian Mycelium A/S has raised €1.25m in a financing round led by Nippon Beet Sugar Manufacturing Co., Ltd. (Nitten), Japan’s largest beet sugar producer, to scale-up its mycoprotein … more ➔
Adobe Stock - TechArtTrends Personalised medicineReproducible nanopore sequencing to be commercialised from 2026For nearly two decades, Roche AG has been searching for a next-generation sequencing method in personalised medicine to overcome the limitations of short read lengths in existing sequencing technologies. … more ➔
adobe stock.com - EtiAmmos 
BIO-CAT
Frederick Bernas
EFPIA
Bristol Myers Squibb
Invest in Scotland, FlexBio
MichaelVi - stock.adobe.com
EC
Norwegian Mycelium AS
Adobe Stock - TechArtTrends